Chefs' Warehouse, Inc.: Form 10-Q for the period ended Sep 23, 2022
Filed with the SEC on Oct 26, 2022 and accepted by EDGAR at Oct 26, 2022, 09:21 ET.
Management's discussion and analysis
As filed, 20,565 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided as a supplement to the accompanying consolidated financial statements and footnotes to help provide an understanding of our financial condition, changes in our financial condition and results of operations. The following discussion should be read in conjunction with information included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 22, 2022. Unless otherwise indicated, the terms “Company”, “Chefs’ Warehouse”, “we”, “us” and “our” refer to The Chefs’ Warehouse, Inc. and its subsidiaries.
Business Overview
We are a premier distributor of specialty foods in nine of the leading culinary markets in the United States. We offer more than 50,000 stock-keeping units (“SKUs”), ranging from high-quality specialty foods and ingredients to basic ingredients and staples and center-of-the-plate proteins. We serve more than 35,000 customer locations, primarily located in our nineteen geographic markets across the United States and Canada, and the majority of our customers are independent restaurants and fine dining establishments. We also sell certain of our products directly to consumers through our Allen Brothers and “Shop Like a Chef” retail channels.
Effect of the COVID-19 Pandemic on our Business and Operations
The COVID-19 pandemic (“Pandemic”) had an adverse impact on numerous aspects of our business and those of our customers including, but not limited to, demand for our products, cost inflation and labor shortages. Despite these challenges, we continued to provide our core customers with high touch service, executed on our cost control measures and returned to profitability beginning in the second quarter of fiscal 2021. We continue to experience sequential improvement in our business which has contributed to organic sales growth of $107.2 million compared to the prior year quarter.
The extent to which the Pandemic may impact our financial condition or results of operations is uncertain and will depend on future developments including new information that may emerge on the severity or transmissibility of the disease, new variants, government responses, trends in infection rates, development and distribution of effective medical treatments and vaccines, and future consumer spending behavior, among others.
Recent Acquisitions
On December 28, 2021, pursuant to an asset purchase agreement, we acquired substantially all of the assets of CGC Holdings, Inc. (“Capital Seaboard”), a specialty seafood and produce distributor in Maryland. The purchase price was approximately $31.0 million consisting of $28.0 million paid in cash at closing, common stock warrants of $1.7 million , and $1.3 million paid upon settlement of a net working capital true-up.
During the thirty-nine weeks ended September 23, 2022, the Company completed three other acquisitions for an aggregate purchase price of approximately $32.5 million, paid in cash, subject to customary working capital adjustments. The Company will also pay additional contingent consideration, if earned, in the form of earn-out amounts which could total $2.0 million in the aggregate.
RESULTS OF OPERATIONS
| Thirteen Weeks Ended September 23, 2022 | September 24, 2021 | Thirty-Nine Weeks Ended September 23, 2022 | September 24, 2021 | |
|---|---|---|---|---|
| Net sales | $661,856 | $484,321 | $1,822,063 | $1,187,506 |
| Cost of sales | 504,068 | 374,346 | 1,390,758 | 922,710 |
| Gross profit | 157,788 | 109,975 | 431,305 | 264,796 |
| Selling, general and administrative expenses | 130,255 | 99,431 | 364,828 | 270,034 |
| Other operating expenses (income), net | 5,458 | 105 | 10,504 | (208) |
| Operating income (loss) | 22,075 | 10,439 | 55,973 | (5,030) |
| Interest expense | 10,737 | 4,191 | 19,567 | 13,362 |
| Income (loss) before income taxes | 11,338 | 6,248 | 36,406 | (18,392) |
| Provision for income tax expense (benefit) | 3,061 | 2,792 | 9,829 | (5,025) |
| Net income (loss) | $8,277 | $3,456 | $26,577 | $(13,367) |
Management evaluates the results of operations and cash flows using a variety of key performance indicators, including net sales compared to prior periods and internal forecasts, costs of our products and results of our cost-control initiatives, and use of operating cash. These indicators are discussed throughout the “Results of Operations” and “Liquidity and Capital Resources” sections of this MD&A.
Thirteen Weeks Ended September 23, 2022 Compared to Thirteen Weeks Ended September 24, 2021
Net Sales
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Net sales | $661,856 | $484,321 | $177,535 | 36.7% |
Organic growth contributed $107.2 million, or 22.2%, to sales growth and the remaining sales growth of $70.3 million, or 14.5%, resulted from acquisitions. Organic case count increased approximately 18.3% in our specialty category. In addition, specialty unique customers and placements increased 25.9% and 42.1%, respectively, compared to the prior year period. Organic pounds sold in our center-of-the-plate category increased 11.6% compared to the prior year. Estimated inflation was 15.0% in our specialty category and 2.2% in our center-of-the-plate category compared to the prior year period.
Gross Profit
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Gross profit | $157,788 | $109,975 | $47,813 | 43.5% |
| Gross profit margin | 23.8% | 22.7% |
Gross profit dollars increased primarily as a result of increased sales and price inflation. Gross profit margin increased approximately 113 basis points. Gross profit margins decreased 133 basis points in the Company’s specialty category and increased 238 basis points in the Company’s center-of-the-plate category. Estimated inflation was 15.0% in the Company’s specialty category and 2.2% in the center-of-the-plate category compared to the prior year period. Specialty margins decreased primarily due to significant year-over-year product cost inflation. Margin rates in the center-of-the-plate category increased as a result of the reopening of favorable margin markets versus the same period in 2021 and year-over-year deflation in certain protein categories.
Selling, General and Administrative Expenses
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Selling, general and administrative expenses | $130,255 | $99,431 | $30,824 | 31.0% |
| Percentage of net sales | 19.7% | 20.5% |
19
The increase in selling, general and administrative expenses was primarily due to higher costs associated with compensation and benefits, facilities costs, and fuel costs to support sales growth. Our ratio of selling, general and administrative expenses to net sales decreased predominately due to sales growth which contributed to improved fixed cost leverage in the quarter.
Other Operating Expenses, Net
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Other operating expenses, net | $5,458 | $105 | $5,353 | 5,098.1% |
The increase in net other operating expenses was primarily due to non-cash charges of $4.7 million for changes in the fair value of our contingent earn-out liabilities compared to non-cash credits of $0.1 million in the prior year period.
Interest Expense
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Interest expense | $10,737 | $4,191 | $6,546 | 156.2% |
Interest expense increased primarily due to incurred arrangement and third-party transaction fees of $4.5 million and a $0.1 million loss on debit extinguishment from the refinancing of our term loan. Additionally, we had higher amounts of debt outstanding as a result our $300.0 million term loan issuance in August 2022 and increases in the variable portion of interest rates charged on our outstanding debt.
Provision for Income Taxes
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Provision for income tax expense (benefit) | $3,061 | $2,792 | $269 | 9.6% |
| Effective tax rate | 27.0% | 44.7% |
The effective tax rate in the prior period was driven by various discrete items. The Company’s effective tax rate excluding these discrete items was approximately 29.2%.
Thirty-Nine Weeks Ended September 23, 2022 Compared to Thirty-Nine Weeks Ended September 24, 2021
Net Sales
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Net sales | $1,822,063 | $1,187,506 | $634,557 | 53.4% |
Organic growth contributed $435.8 million, or 36.7%, to sales growth and the remaining sales growth of $198.8 million, or 16.7%, resulted from acquisitions. Organic case count increased approximately 31.3% in our specialty category. In addition, specialty unique customers and placements increased 30.3% and 46.4%, respectively, compared to the prior year period. Organic pounds sold in our center-of-the-plate category increased 16.4% compared to the prior year. Estimated inflation was 15.5% in our specialty category and 11.6% in our center-of-the-plate category compared to the prior year period.
Gross Profit
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Gross profit | 431,305 | 264,796 | 166,509 | 62.9% |
| Gross profit margin | 23.7% | 22.3% |
Gross profit dollars increased primarily as a result of sales growth and price inflation. Gross profit margin increased approximately 137 basis points. Gross profit margins decreased 31 basis points in the Company’s specialty category and increased 202 basis points in the Company’s center-of-the-plate category. Estimated inflation was 15.5% in our specialty category and 11.6% in our center-of-the-plate category compared to the prior year period. Higher inflation compressed margin rates in the specialty categories, while margin rates in the center-of-the-plate category were buoyed primarily by the reopening of favorable margin markets in the 2022 period.
Selling, General and Administrative Expenses
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Selling, general and administrative expenses | 364,828 | 270,034 | 94,794 | 35.1% |
| Percentage of net sales | 20.0% | 22.7% |
The increase in selling, general and administrative expenses was primarily due to higher costs associated with compensation and benefits, facilities costs, and fuel costs to support sales growth. Our ratio of selling, general and administrative expenses to net sales decreased predominately due to sales growth which contributing to improved fixed cost leverage in the quarter.
Other Operating Expenses (Income ), Net
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Other operating expenses (income), net | 10,504 | (208) | 10,712 | (5,150.0)% |
The increase in net other operating expense relates primarily to non-cash charges of $8.4 million for changes in the fair value of our contingent earn-out liabilities in the fiscal 2022 period compared to non-cash credits of $1.4 million in the prior year period. The prior year period also includes a $0.6 million impairment of Cambridge trademarks as a result of a shift in brand strategy to leverage our Allen Brothers brand in our New England region during the second quarter of fiscal 2021.
Interest Expense
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Interest expense | 19,567 | 13,362 | 6,205 | 46.4% |
Interest expense increased primarily due to incurred arrangement and third-party transaction fees of $4.5 million and a $0.1 million loss on debit extinguishment from the refinancing of our term loan. Additionally, we had higher amounts of debt outstanding as a result our $300.0 million term loan issuance in August 2022 and increases in the variable portion of interest rates charged on our outstanding debt.
Provision for Income Taxes
| 2022 | 2021 | $ Change | % Change | |
|---|---|---|---|---|
| Provision for income tax expense (benefit) | 9,829 | (5,025) | 14,854 | (295.6)% |
| Effective tax rate | 27.0% | 27.3% |
The increase in income tax expense is due to pre-tax income in the current period compared to a pre-tax loss in the prior year period.
LIQUIDITY AND CAPITAL RESOURCES
We finance our day-to-day operations and growth primarily with cash flows from operations, borrowings under our senior secured credit facilities and other indebtedness, operating leases, trade payables and equity financing.
Indebtedness
The following table presents selected financial information on our indebtedness (in thousands):
| September 23, 2022 | December 24, 2021 | |
|---|---|---|
| Senior secured term loan | $300,000 | $168,675 |
| Total convertible debt | 204,000 | 204,000 |
| Borrowings outstanding on asset-based loan facility | — | 20,000 |
| Finance leases and other financing obligations | 9,732 | 11,602 |
| Total | $513,732 | $404,277 |
As of September 23, 2022, we have various floating- and fixed-rate debt instruments with varying maturities for an aggregate principal amount of $504.0 million.
On August 23, 2022, we entered into an eighth amendment to its senior secured term loan credit agreement in which we borrowed $300.0 million maturing on August 23, 2029. See Note 9 “Debt Obligations” to our consolidated financial statements for a full description.
On March 11, 2022, we entered into a third amendment to our asset-based loan facility ABL Facility which increased the aggregate commitments from $150.0 million to $200.0 million. See Note 9 “Debt Obligations” to our consolidated financial statements for a full description.
Liquidity
The following table presents selected financial information on liquidity (in thousands):
| September 23, 2022 | December 24, 2021 | |
|---|---|---|
| Cash and cash equivalents | $145,425 | $115,155 |
| Working capital, excluding cash and cash equivalents | 209,181 | 157,787 |
| Availability under asset-based loan facility | 176,820 | 109,459 |
| Total | $531,426 | $382,401 |
We expect our capital expenditures, excluding cash paid for acquisitions, for fiscal 2022 will be approximately $36.0 million to $45.0 million. We believe our existing balances of cash and cash equivalents, working capital and the availability under our asset-based loan facility, are sufficient to satisfy our working capital needs, capital expenditures, debt service and other liquidity requirements associated with our current operations over the next 12 months.
Cash Flows
The following table presents selected financial information on cash flows (in thousands):
| Thirty-Nine Weeks Ended September 23, 2022 | September 24, 2021 | |
|---|---|---|
| Net income (loss) | $26,577 | $(13,367) |
| Non-cash charges | $58,763 | $30,729 |
| Changes in working capital | $(53,593) | $(43,692) |
| Net cash provided by (used in) operating activities | $31,747 | $(26,330) |
| Net cash used in investing activities | $(93,673) | $(25,152) |
| Net cash provided by (used in) financing activities | $92,255 | $(7,493) |
22
Net cash provided by operations was $31.7 million for the thirty-nine weeks ended September 23, 2022 compared to net cash used in operating activities of consisting of $13.4 million for the thirty-nine weeks ended September 24, 2021. The increase in cash provided by operating activities was primarily due to the increased net income, net of non-cash charges, in the current year of $85.3 million compared to $17.4 million in the prior year period. This improvement in cash-based profitability is primarily due to a 53.4% increase in sales compared to the prior year period. The sales growth also resulted in higher working capital (increased accounts receivable and inventory partially offset by higher accounts payable). The working capital growth of $9.9 million versus the prior year period partially offset the favorable impact of increased cash-based profitability. The Company’s increased working capital investment in the current year is the result of rapid sales growth driven by our recovery from the pandemic. We expect working capital growth to moderate in the future as sales growth normalizes.
Net cash used in investing activities was $93.7 million for the thirty-nine weeks ended September 23, 2022, driven by capital expenditures of $31.7 million which includes the purchase of our distribution facility in Columbus, Ohio and $62.0 million in cash paid for acquisitions.
Net cash provided financing activities was $92.3 million for the thirty-nine weeks ended September 23, 2022 driven by the $300.0 million issuance of senior secured term loans maturing in 2029 (“2029 Term Loans”). This was partially offset by $171.4 million of principal payments predominately driven by the pay off our 2025 tranche of senior secured term loans and $11.3 million of deferred financing fees paid in connection with the 2029 Term Loans. We paid $20.0 million to pay down all borrowings outstanding on our asset based loan facility. We also paid $2.6 million for shares surrendered to pay tax withholding related to the vesting of equity incentive plan awards and $2.5 million of earn-out liability payments classified as financing activities.
Seasonality
Excluding our direct-to-consumer business, we generally do not experience any material seasonality. However, our sales and operating results may vary from quarter to quarter due to factors such as changes in our operating expenses, management’s ability to execute our operating and growth strategies, personnel changes, demand for our products, supply shortages, weather patterns and general economic conditions.
Our direct-to-consumer business is subject to seasonal fluctuations, with direct-to-consumer center-of-the-plate protein sales typically higher during the holiday season in our fourth quarter; accordingly, a disproportionate amount of operating cash flows from this portion of our business is generated by our direct-to-consumer business in the fourth quarter of our fiscal year. Despite a significant portion of these sales occurring in the fourth quarter, there are operating expenses, principally advertising and promotional expenses, throughout the year.
The Pandemic has had a material impact on our business and operations and those of our customers. Our net sales were most significantly impacted during the second quarter of fiscal 2020 when, in an effort to limit the spread of the virus, federal, state and local governments began implementing various restrictions that resulted in the closure of non-essential businesses in many of the markets we serve, which forced our customers in those markets to either transition their establishments to take-out service, delivery service or temporarily cease operations.
Inflation
Our profitability is dependent on, among other things, our ability to anticipate and react to changes in the costs of key operating resources, including food and other raw materials, labor, energy and other supplies and services. Substantial increases in costs and expenses could impact our operating results to the extent that such increases cannot be passed along to our customers. The impact of inflation and deflation on food, labor, energy and occupancy costs can significantly affect the profitability of our operations.
Critical Accounting Policies and Estimates
The preparation of the Company’s consolidated financial statements requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The SEC has defined critical accounting policies as those that are both most important to the portrayal of the Company’s financial condition and results and require its most difficult, complex or subjective judgments or estimates. Based on this definition, we believe our critical accounting policies include the following: (i) determining our allowance for doubtful accounts, (ii) inventory valuation, with regard to determining inventory balance adjustments for excess and obsolete inventory, (iii) business combinations, (iv) valuing goodwill and intangible assets, (v) self-insurance reserves, (vi) accounting for income taxes and (vii)
contingent earn-out liabilities. Our critical accounting policies and estimates are described in the Form 10-K filed with the SEC on February 22, 2022.
Market risk
As filed, 333 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Interest Rate Risk
As of September 23, 2022, we had an aggregate $300.0 million of indebtedness outstanding under the Term Loan that bore interest at variable rates. A 100 basis point increase in market interest rates would decrease our after tax earnings by approximately $2.2 million per annum, holding other variables constant.
Controls and procedures
As filed, 958 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of September 23, 2022.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 23, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 351 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 24, 2021 filed with the SEC on February 22, 2022. In addition to the information contained herein, you should consider the risk factors disclosed in our Annual Report on Form 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-23. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-06-25 to 2022-09-23 | $661.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-12-25 to 2022-09-23 | $1.82bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-06-25 to 2022-09-23 | $504.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-12-25 to 2022-09-23 | $1.39bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-06-25 to 2022-09-23 | $157.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-12-25 to 2022-09-23 | $431.3m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-06-25 to 2022-09-23 | $130.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2021-12-25 to 2022-09-23 | $364.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-06-25 to 2022-09-23 | $22.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-12-25 to 2022-09-23 | $56.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-06-25 to 2022-09-23 | $10.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-12-25 to 2022-09-23 | $19.6m | us-gaap:InterestExpense |
| Income tax | 3 months2022-06-25 to 2022-09-23 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-12-25 to 2022-09-23 | $9.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-06-25 to 2022-09-23 | $8.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-12-25 to 2022-09-23 | $26.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-06-25 to 2022-09-23 | $0.21 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-12-25 to 2022-09-23 | $0.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-06-25 to 2022-09-23 | $0.22 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-12-25 to 2022-09-23 | $0.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-06-25 to 2022-09-23 | 42,044,053 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-12-25 to 2022-09-23 | 41,942,676 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-12-25 to 2022-09-23 | $31.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-12-25 to 2022-09-23 | $31.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2022-09-23 | $145.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-23 | $591.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-23 | $1.25bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-23 | $236.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-23 | $867.8m | us-gaap:Liabilities |
| Long-term debt | At period end2022-09-23 | $493.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-09-23 | $6.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-09-23 | $384.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001517175-22-000012. Last ingested by Listed: Nov 15, 2026, 01:17 ET. Listed shows no prices and gives no investment advice.